| Literature DB >> 22359583 |
Yong Nie1, Yue-Qin Tang, Yan Li, Chang-Qiao Chi, Man Cai, Xiao-Lei Wu.
Abstract
Polymorphum gilvum SL003B-26A1(T) is the type strain of a novel species in the recently published novel genusEntities:
Mesh:
Substances:
Year: 2012 PMID: 22359583 PMCID: PMC3281065 DOI: 10.1371/journal.pone.0031261
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Circular chromosome of Polymorphum gilvum SL003B-26A1T.
The scale on the outside indicates the size. Position 1 of the chromosome was assigned to the first nucleotide of the dnaA gene. Rings 1 and 2 (from the outside in) indicate the genes in forward and reverse strands respectively, the colors of the genes indicate the COG categories, as indicated in the figure. Rings 3 and 4 indicate the G+C content and GC skew [(C−G)/(C+G)], respectively. Circular genome map was generated by CGview [78].
Key features of the Polymorphum gilvum SL003B-26A1T genome.
| Feature | Chromosome | Plasmid |
| Size (bp) | 4,649,365 | 69,598 |
| G+C content (%) | 67.22 | 61.55 |
| CDS (protein coding genes) | 4322 | 71 |
| Coding density | 88.7 | 88.63 |
| Avg of CDS length (bp) | 955 | 869 |
| genes with COGs | 3532 | 46 |
| No. of tRNA genes | 50 | 0 |
| No. of rRNA operons | 2 | 0 |
Figure 2Taxonomic distribution analysis of the Polymorphum gilvum SL003B-26A1T proteome.
Figure 3An overview of metabolism and transport in Polymorphum gilvum SL003B-26A1T.
Figure 4Gene clusters involved in aromatic compounds metabolisms in SL003B-26A1 and putative metabolic pathways.
A: Gene clusters involved in aromatic compounds metabolisms. B: Putative pathways of aromatic compounds metabolisms. pcaD, 3-oxoadipate enol-lactonase; pcaC, 4-carboxymuconolactone decarboxylase; pcaH, protocatechuate 3,4-dioxygenase, beta subunit; pcaG, protocatechuate 3,4-dioxygenase, alpha subunit; , glutaconate CoA-transferase, subunit A; gctB, glutaconate CoA-transferase, subunit B; fadA, acetyl-CoA acyltransferase; pcaB, 3-carboxy-cis,cis-muconate cycloisomerase; pobA, p-hydroxybenzoate 3-monooxygenase; araC, AraC-type DNA-binding domain-containing proteins; lysR, putative LysR family transcriptional regulator; ligI, 2-pyrone-4,6-dicarboxylate lactonase; orf1, TRAP-type uncharacterized transport system, fused permease components; orf2, TRAP-type uncharacterized transport system, periplasmic component; orf3, hypothetical protein; orf4, demethylmenaquinone methyltransferase; orf5, GlcNAc-PI de-N-acetylase family protein; xylE, catechol 2,3-dioxygenase; orf6, hypothetical protein; orf7, 3-hydroxyisobutyrate dehydrogenase and related beta-hydroxyacid dehydrogenases; vanB, vanillate monooxygenase, subunit B; vanR, GntR family transcriptional regulator, vanillate catabolism transcriptional regulator; vanA, vanillate monooxygenase, subunit A; bphAa, biphenyl 2,3-dioxygenase, large subunit; bphAb, biphenyl 2,3-dioxygenase, small subunit; fdx, ferredoxin; bphB, cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase; ADH, aldehyde dehydrogenase; p450, cytochrome P450 family protein; orf8, 2-keto-4-pentenoate hydratase/2-oxohepta-3-ene-1,7-dioic acid hydratase; marR, MarR family transcription regulator protein; ligA, protocatechuate 4,5-dioxygenase, alpha chain; ligB, protocatechuate 4,5-dioxygenase, beta chain; catA, catechol 1,2-dioxygenase; catB, muconate cycloisomerase; catC, muconolactone D-isomerase; mph, phenol 2-monooxygenase; nah, salicylate 1-monooxygenase; mhpD, 2-keto-4-pentenoate hydratase; mhpE, 4-hydroxy 2-oxovalerate aldolase; mhpF, acetaldehyde dehydrogenase.